πŸ‡ΊπŸ‡Έ FDA
Patent

US 11497735

Conjoint therapies for immunomodulation

granted A61KA61K31/4245A61K45/06

Quick answer

US patent 11497735 (Conjoint therapies for immunomodulation) held by Aurigene Discovery Technologies Limited expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/4245, A61K45/06, A61P, A61P35/00